Clinical and laboratory diagnostic characteristics and cytotoxigenic potential of Hafnia alvei and Hafnia paralvei strains

Journal of Clinical Microbiology

Volumn 49, Issue 9, 2011, Pages 3122-3126

  Abbott, Sharon L ^a   Moler, Silvia ^a   Green, Nicole ^a,b   Tran, Robert K ^a,c   Wainwright, Katlyn ^a   Janda, J Michael ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b Public Health Laboratory   (United States)

^c San Mateo County Public Health Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; ARABINOSE; AZTREONAM; BETA GLUCOSIDASE; CEFACLOR; CEFEPIME; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GATIFLOXACIN; GENTAMICIN; IMIPENEM; MALONIC ACID; MEROPENEM; OFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SALICIN; SULTAMICILLIN; TETRACYCLINE; TIMENTIN;

AMPC GENE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; CYTOLYSIS; ENZYME ACTIVITY; FERMENTATION; GENE SEQUENCE; GENETIC VARIABILITY; HAFNIA; HAFNIA ALVEI; HAFNIA PARALVEI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPECIES DIFFERENTIATION; TEST STRIP; VERO CELL;

BACTERIAL PROTEINS; BACTERIOLOGICAL TECHNIQUES; BETA-LACTAMASES; BIOLOGICAL MARKERS; ENTEROBACTERIACEAE INFECTIONS; HAFNIA; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR DIAGNOSTIC TECHNIQUES;

HAFNIA; HAFNIA ALVEI;

EID: 80052228169     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00866-11     Document Type: Article

References (27)

1. Benito, M. H., R. Sánchez Hernández, M. J. Fernández-Reyes Luis, and S. Hernando. 2008. Sepsis induced by Hafnia alvei in a kidney transplant patient. Nefrologia 28:470-471.
2. Brenner, D. J. 1978. Characterization and clinical identification of Enterobacteriaceae by DNA hybridization. Prog. Clin. Pathol. 7:71-117.
3. Brenner, D. J. 1981. Introduction to the family Enterobacteriaceae, p. 1105-1127. In M. P. Starr, H. Stolp, H. G. Trüper, A. Balows, and H. G. Schlegel (ed.), The prokaryotes: a handbook on habitats, isolation, and identification. Springer-Verlag, New York, NY.
4. British Society for Antimicrobial Chemotherapy. 2010. BSAC methods for antimicrobial susceptibility testing, version 9.1, March 2010. British Society for Antimicrobial Chemotherapy, Birmingham, United Kingdom.
5. Candoni, A., R. Trevisan, C. Fili, M. Tribelli, and R. Fanin. 2004. Abdominal abscess and Hafnia alvei septicemia occurring during the aplastic phase after autologous stem-cell transplantation in a patient with diffuse large B-cell lymphoma. J. Infect. Chemother. 10:303-306.
6. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing: twentieth informational supplement. CLSI document M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Crandall, C., S. L. Abbott, Y. Q. Zhao, W. Probert, and J. M. Janda. 2006. Isolation of toxigenic Hafnia alvei from a probable case of hemolytic uremic syndrome. Infection 34:227-229.
8. Donato, K. A., et al. 2008. Escherichia albertii and Hafnia alvei are candidate enteric pathogens with divergent effects on intracellular tight junctions. Microb. Pathog. 45:377-385.
9. Englund, G. W. 1969. Persistent septicemia due to Hafnia alvei. Am. J. Clin. Pathol. 51:717-719.
10. European Committee on Antimicrobial Susceptibility Testing. 2010. Rationale for the EUCAST clinical breakpoints, v. 1.0. European Society of Clinical Microbiology and Infectious Diseases, Basel Switzerland.
11. Girlich, D., et al. 2000. Heterogeneity of AmpC cephalosporinases of Hafnia alvei clinical isolates expressing inducible or constitutive ceftazidime resistance phenotypes. Antimicrob. Agents Chemother. 44:3220-3223.
12. Günthard, H., and A. Pennekamp. 1996. Clinical significance of extraintestinal Hafnia alvei isolates from 61 patients and review of the literature. Clin. Infect. Dis. 22:1040-1045.
13. Huys, G., M. Cnockaert, S. L. Abbott, J. M. Janda, and P. Vandamme. 2010. Hafnia paralevi sp. nov., formerly known as H. alvei hybridization group 2. Int. J. Syst. Evol. Microbiol. 60:1725-1728.
14. Janda, J. M., and S. L. Abbott. 2006. The enterobacteria, 2nd ed. ASM Press, Washington, DC.
15. Janda, J. M., and S. L. Abbott. 2006. The genus Hafnia: from soup to nuts. Clin. Microbiol. Rev. 19:12-18.
16. Janda, J. M., S. L. Abbott, S. Bystrom, and W. S. Probert. 2005. Identification of two distinct hybridization groups in the genus Hafnia by 16S rRNA gene sequencing and phenotypic methods. J. Clin. Microbiol. 43:3320-3323.
17. Janda, J. M., S. L. Abbott, S. Khashe, and W. Probert. 2002. Phenotypic and genotypic properties of the genus Hafnia. J. Med. Microbiol. 51:575-580.
18. Jennis, F., and S. W. McCarthy. 1967. Hafnia: an unusual cause of post-operative gram-negative bacteriae [sic]. Med. J. Aust. 1(6):286-287.
19. Podschun, R., A. Fischer, and U. Ullmann. 2001. Characterisation of Hafnia alvei isolates from human clinical extra-intestinal specimens: haemagglutinins, serum resistance and siderophore synthesis. J. Med. Microbiol. 50: 208-214.
20. Ratnam, S. 1991. Etiologic role of Hafnia alvei in human diarrheal illness. Infect. Immun. 59:4744-4745.
21. Savini, V., et al. 2009. Isolation of colistin-resistant Hafnia alvei. J. Med. Microbiol. 58:278-280.
22. Savini, V., G. Di Bonaventura, C. Catavitello, R. Piccolomini, and D. D'Antonio. 2008. An unexpected isolate of Hafnia alvei with reduced susceptibility to cefoxitin. J. Infect. 57:165-166.
23. Savini, V., et al. 2008. Graft versus host-related Hafnia alvei colonization and probable infection. J. Med. Microbiol. 57:1167-1169.
24. Skurnik, D., et al. 2010. Emergence of carbapenem-resistant Hafnia: the fall of the last soldier. Clin. Infect. Dis. 50:1429-1431.
25. Steigerwalt, A. G., G. R. Fanning, M. A. Fife-Asbury, and D. J. Brenner. 1976. DNA relatedness among species of Enterobacter and Serratia. Can. J. Microbiol. 22:121-137.
26. Tamura, K., J. Dudley, M. Nei, and S. Kumar. 2007. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24:1596-1599.
27. Thomson, K. S., C. C. Sanders, and J. A. Washington II. 1993. Ceftazidime resistance in Hafnia alvei. Antimicrob. Agents Chemother. 37:1375-1376.